Swiss open enforcement case against Credit Suisse in spy affair

This post was originally published on this siteZURICH (Reuters) – Switzerland’s financial supervisor has opened enforcement proceedings against Credit Suisse (CSGN.S) over a spying

Read More

Swiss watchdog opens enforcement case against Credit Suisse in spy affair

This post was originally published on this siteZURICH (Reuters) – Swiss financial supervisor FINMA said on Wednesday it has opened enforcement proceedings against Credit Suisse (CSGN.S) in

Read More

Sulzer buys Swiss-German device maker Haselmeier for 100 million euros

This post was originally published on this siteZURICH (Reuters) – Sulzer (SUN.S) said on Monday it will buy Swiss-German drug delivery device maker Haselmeier for an enterprise value of 100

Read More

Novartis wins FDA approval to repurpose leukaemia drug against multiple sclerosis

This post was originally published on this siteZURICH (Reuters) – Novartis on Thursday won U.S. Food and Drug Administration (FDA) approval to repurpose an 11-year-old blood cancer drug

Read More

Roche, Regeneron link up on COVID-19 antibody cocktail

This post was originally published on this siteZURICH (Reuters) – Regeneron and Roche said on Wednesday they will collaborate on an investigational antibody cocktail against COVID-19, with

Read More

Roche sales hit by lockdowns, despite COVID-19 test boost

This post was originally published on this siteZURICH (Reuters) – A surge in demand for Roche’s (ROG.S) COVID-19 tests, as some governments even sent military jets to pick up

Read More

Biogen to study Spinraza in combination with $2 million Novartis drug

This post was originally published on this site(Reuters) – One of medicine’s costliest treatment areas could become even more pricey as Biogen seeks to layer its $750,000 spinal

Read More

Novartis tightens outlook as second quarter sales, profit fall

This post was originally published on this siteZURICH (Reuters) – Swiss drugmaker Novartis (NOVN.S) cut its 2020 sales outlook on Tuesday after second quarter sales and profit fell, as

Read More

Novartis tightens outlook as second quarter sales, profit fall

This post was originally published on this siteZURICH (Reuters) – Swiss drugmaker Novartis (NOVN.S) cut its 2020 sales outlook on Tuesday after second quarter sales and profit fell, as

Read More

Novartis to provide ‘no profit’ COVID-19 drugs to low-income countries

This post was originally published on this siteZURICH (Reuters) – Novartis’s Sandoz division will not make a profit on 15 generic drugs it is making available to developing countries

Read More